Cushing Capital Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.51M Sell
6,161
-1,182
-16% -$275K 1.16% 28
2025
Q4
$1.52M Sell
7,343
-271
-4% -$53.6K 1.13% 29
2025
Q3
$1.41M Buy
7,614
+5,440
+250% +$932K 1.11% 28
2025
Q2
$332K Buy
2,174
+14
+0.6% +$2.15K 0.28% 70
2025
Q1
$358K Buy
2,160
+13
+0.6% +$2.03K 0.32% 67
2024
Q4
$310K Buy
+2,147
New +$333K 0.3% 67

Other funds holding JNJ

Cushing Capital Partners's JNJ Position: Q1 2026 in Review

Cushing Capital Partners reduced its Johnson & Johnson (JNJ) stake by 16% in Q1 2026, selling an estimated $275K and leaving 6,161 shares worth $1.51M. The position accounts for 1.16% of the portfolio, ranked #28.

Cushing Capital Partners first reported a position in JNJ in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.52M in Q4 2025. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Cushing Capital Partners held 6,161 shares of Johnson & Johnson worth $1.51M as of Q1 2026.
  • Cushing Capital Partners sold 1,182 Johnson & Johnson shares in Q1 2026, an estimated $275K.
  • Johnson & Johnson made up 1.16% of Cushing Capital Partners's portfolio in Q1 2026, its #28 holding.
  • Cushing Capital Partners first reported a position in Johnson & Johnson in Q4 2024 and has held it in 6 quarters since.
  • Cushing Capital Partners's Johnson & Johnson position peaked at $1.52M in Q4 2025.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Cushing Capital Partners's 13F filing for Q1 2026, filed 20 Apr 2026.